Skip to content
healthcare.dev

anagrelide

NDC 13668-453, anagrelide, capsule, from Torrent Pharmaceuticals Limited.

Product NDC
13668-453
Status
Listed
Labeler
Torrent Pharmaceuticals Limited
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209151
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13668-453 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANAGRELIDE HYDROCHLORIDE ANHYDROUS.5 mg/1

Pharmacologic classes

Decreased Platelet Production [PE]; Phosphodiesterase 3 Inhibitors [MoA]; Platelet-reducing Agent [EPC]

Package NDCNDC-11Package
13668-453-0113668045301100 CAPSULE in 1 BOTTLE (13668-453-01)
13668-453-301366804533030 CAPSULE in 1 BOTTLE (13668-453-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/875cc32a-219c-4b6b-802a-98a47cbc9a78
  • NADAC price for package 13668045301

    GET /v1/drugs/nadac/13668045301

Use it

Look up 13668-453 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13668-453 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13668-453. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.